Literature DB >> 3342760

Regulation of progesterone receptor messenger ribonucleic acid and protein levels in MCF-7 cells by estradiol: analysis of estrogen's effect on progesterone receptor synthesis and degradation.

A M Nardulli1, G L Greene, B W O'Malley, B S Katzenellenbogen.   

Abstract

The human breast cancer cell line MCF-7 responds to estrogens with increased progesterone receptor (PR) levels. In this study, we use dense amino acid density shift analyses to address directly the question of whether estrogen increases PR levels in MCF-7 cells by altering rates of receptor synthesis and/or degradation. Using different concentrations of estradiol (E2), which achieve PR levels that are half-maximal (3 X 10(-11) M F2) or maximal (6 X 10(-11) M E2), we have done sucrose gradient density shift analyses using dense (15N, 13C, 2H) amino acid incorporation to study rates of PR synthesis and degradation. These studies reveal a nonlinear loss of preexisting normal density receptor with time. From kinetic modeling analyses, equivalent rates of degradation are estimated for PR whether maximal or half-maximal levels are maintained, indicating that the major effect of E2 on PR content is to increase the rate of PR synthesis while leaving the degradation rate unaltered. The E2-stimulated increase in PR protein is also associated with increased levels of PR mRNA, as demonstrated by the use of a human PR cDNA probe. These density shift data provide evidence that the increased PR levels after estrogen exposure in MCF-7 cells are the result of an increased rate of receptor synthesis, rather than modulation of the rate of receptor degradation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3342760     DOI: 10.1210/endo-122-3-935

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  43 in total

Review 1.  Minireview: Switching on progesterone receptor expression with duplex RNA.

Authors:  Bethany A Janowski; David R Corey
Journal:  Mol Endocrinol       Date:  2010-06-30

2.  Cutting SRC-1 down to size in endometriosis.

Authors:  Matthew T Dyson; Serdar E Bulun
Journal:  Nat Med       Date:  2012-07-06       Impact factor: 53.440

Review 3.  Role of estrogen receptor-β in endometriosis.

Authors:  Serdar E Bulun; Diana Monsavais; Mary Ellen Pavone; Matthew Dyson; Qing Xue; Erkut Attar; Hideki Tokunaga; Emily J Su
Journal:  Semin Reprod Med       Date:  2012-01-23       Impact factor: 1.303

4.  Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland.

Authors:  Paola Mussi; Lan Liao; Seong-Eun Park; Paolo Ciana; Adriana Maggi; Benita S Katzenellenbogen; Jianming Xu; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-25       Impact factor: 11.205

5.  Discovery of estrogen-responsive genes using an improved method which combines subtractive hybridization and PCR.

Authors:  W Liu; W Su; T M Roberts
Journal:  Nucleic Acids Res       Date:  1998-08-01       Impact factor: 16.971

6.  Parity and expression of epithelial histopathologic markers in breast tissue.

Authors:  Yukiko Morimoto; Jeffrey Killeen; Brenda Y Hernandez; J Mark Cline; Gertraud Maskarinec
Journal:  Eur J Cancer Prev       Date:  2013-09       Impact factor: 2.497

7.  Long-range transcriptional control of progesterone receptor gene expression.

Authors:  Jamie Bonéy-Montoya; Yvonne S Ziegler; Carol D Curtis; Jonathan A Montoya; Ann M Nardulli
Journal:  Mol Endocrinol       Date:  2009-12-01

8.  Progestin inhibition of estrogen-dependent proliferation in ZR-75-1 human breast cancer cells: antagonism by insulin.

Authors:  R Poulin; J M Dufour; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

9.  Soy consumption and histopathologic markers in breast tissue using tissue microarrays.

Authors:  Gertraud Maskarinec; Eva Erber; Martijn Verheus; Brenda Y Hernandez; Jeffrey Killeen; Suzanne Cashin; J Mark Cline
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

10.  Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Authors:  Hiroyuki Yamaguchi; Shigeru Kamiya; Tomonori Uruma; Takako Osaki; Haruhiko Taguchi; Tomoko Hanawa; Minoru Fukuda; Hayato Kawakami; Hajime Goto; Herman Friedman; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.